Biovica says Pharma Services head Henrik exits as company reviews leadership to bolster CDx push

• Biovica said Pharma Services head Henrik will leave as the company reviews leadership needs for its expanding pharma offering.
• The review targets added capability in companion diagnostics development, aiming to support CDx agreement(s) with pharma partners.
• Ongoing pharma work orders and customer projects will be handled by the existing Pharma Services team.
• Pharma Services revenue rose 95% in the first quarter of the financial year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovica International AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.